IOL CHEMICALS & PHARM. | SANOFI INDIA | IOL CHEMICALS & PHARM./ SANOFI INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 31.6 | 43.2% | View Chart |
P/BV | x | 1.6 | 20.1 | 7.7% | View Chart |
Dividend Yield | % | 1.0 | 2.0 | 49.6% |
IOL CHEMICALS & PHARM. SANOFI INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SANOFI INDIA Dec-23 |
IOL CHEMICALS & PHARM./ SANOFI INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 8,278 | 6.5% | |
Low | Rs | 272 | 5,240 | 5.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 1,238.0 | 30.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | 261.8 | 9.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 279.0 | 11.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 167.00 | 2.4% | |
Avg Dividend yield | % | 1.0 | 2.5 | 40.0% | |
Book value per share (Unadj.) | Rs | 256.8 | 411.2 | 62.5% | |
Shares outstanding (eoy) | m | 58.71 | 23.03 | 254.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 5.5 | 19.6% | |
Avg P/E ratio | x | 17.1 | 25.8 | 66.1% | |
P/CF ratio (eoy) | x | 12.8 | 24.2 | 52.9% | |
Price / Book Value ratio | x | 1.6 | 16.4 | 9.6% | |
Dividend payout | % | 16.9 | 63.8 | 26.5% | |
Avg Mkt Cap | Rs m | 23,743 | 155,659 | 15.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 3,706 | 45.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 28,511 | 77.8% | |
Other income | Rs m | 256 | 665 | 38.5% | |
Total revenues | Rs m | 22,427 | 29,176 | 76.9% | |
Gross profit | Rs m | 2,257 | 8,203 | 27.5% | |
Depreciation | Rs m | 462 | 396 | 116.6% | |
Interest | Rs m | 165 | 17 | 968.8% | |
Profit before tax | Rs m | 1,887 | 8,455 | 22.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 2,426 | 20.4% | |
Profit after tax | Rs m | 1,391 | 6,029 | 23.1% | |
Gross profit margin | % | 10.2 | 28.8 | 35.4% | |
Effective tax rate | % | 26.2 | 28.7 | 91.5% | |
Net profit margin | % | 6.3 | 21.1 | 29.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 31,314 | 30.9% | |
Current liabilities | Rs m | 5,025 | 25,347 | 19.8% | |
Net working cap to sales | % | 20.9 | 20.9 | 100.0% | |
Current ratio | x | 1.9 | 1.2 | 155.7% | |
Inventory Days | Days | 43 | 159 | 27.2% | |
Debtors Days | Days | 8 | 17 | 49.3% | |
Net fixed assets | Rs m | 11,017 | 15,714 | 70.1% | |
Share capital | Rs m | 587 | 230 | 255.3% | |
"Free" reserves | Rs m | 14,490 | 9,239 | 156.8% | |
Net worth | Rs m | 15,077 | 9,469 | 159.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 47,028 | 44.0% | |
Interest coverage | x | 12.5 | 498.4 | 2.5% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.6 | 176.8% | |
Return on assets | % | 7.5 | 12.9 | 58.5% | |
Return on equity | % | 9.2 | 63.7 | 14.5% | |
Return on capital | % | 13.6 | 89.5 | 15.2% | |
Exports to sales | % | 26.7 | 18.0 | 148.3% | |
Imports to sales | % | 0 | 25.2 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 5,143 | 115.3% | |
Imports (cif) | Rs m | NA | 7,177 | 0.0% | |
Fx inflow | Rs m | 5,930 | 5,143 | 115.3% | |
Fx outflow | Rs m | 6,052 | 7,177 | 84.3% | |
Net fx | Rs m | -122 | -2,034 | 6.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 2,304 | 53.1% | |
From Investments | Rs m | -1,200 | 375 | -320.0% | |
From Financial Activity | Rs m | -41 | -8,783 | 0.5% | |
Net Cashflow | Rs m | -18 | -6,104 | 0.3% |
Indian Promoters | % | 48.2 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 60.4 | - | |
Indian inst/Mut Fund | % | 1.7 | 29.0 | 5.9% | |
FIIs | % | 1.4 | 6.1 | 22.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 39.6 | 130.8% | |
Shareholders | 130,003 | 61,849 | 210.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Sanofi India | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | 1.76% | 0.45% |
1-Month | 5.76% | 7.36% | 2.55% |
1-Year | -2.63% | 38.51% | 56.14% |
3-Year CAGR | -12.88% | 3.63% | 15.22% |
5-Year CAGR | 16.82% | 8.02% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Sanofi India share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Sanofi India the stake stands at 60.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Sanofi India.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Sanofi India paid Rs 167.0, and its dividend payout ratio stood at 63.8%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Sanofi India.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.